circAβ-a RNA encoded Aβ175--the hidden driver of β-amyloid plaque formation and deposition in sporadic Alzheimer's disease.
Mo, D.; Zhao, Y.; Liu, Y.; Brosius, J.; Xiao, G.
Show abstract
Mechanisms that trigger A{beta} production in sporadic Alzheimers disease are still obscure. We recently reported the expression of a human circular RNA (circA{beta}-a) encoded A{beta} peptide precursor variant (A{beta}175). Presently, we demonstrated that AAV9 virus-expressed circA{beta}-a gave rise to extensive extracellular A{beta} plaque depositions and microglial activation in mouse brain; this recapitulates critical pathogenic hallmarks within a sporadic AD mouse model. Specifically developed antibodies detected robust endogenous A{beta}175 expression in HEK293 cells and hNSC-derived human neurons, underscoring the potential of A{beta}175 as a salient A{beta} precursor. Furthermore, we detected high levels of A{beta}175 oligomers in young-adult human brains. In intermediate and old-age human brain samples, accumulation of soluble A{beta}175 pentamers was reduced and A{beta}175 oligomers were components of most insoluble A{beta} plaques in older human brain. We propose a causal relationship between human circA{beta}-a RNA expression, dysregulation of A{beta}175 oligomer processing/aggregation and A{beta} plaque accumulation in sporadic AD.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Opposing roles of physiological and pathological amyloid-β on synapses in live human brain slice cultures 95%
- Plasma p-tau212: antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology 95%
- Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer's disease retina 95%
Similar papers in this journal
- APOE2 gene therapy reduces amyloid deposition, and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease 96%
- The unfolded protein response transcription factor XBP1s ameliorates Alzheimer`s disease by improving synaptic function and proteostasis 95%
- CircTulp4 functions in Alzheimer's disease pathogenesis by regulating its parental gene, Tulp4 94%
Similar papers in this journal
- β-Amyloid Induces Microglial Expression of GPC4 and APOE Leading to Increased Neuronal Tau Pathology and Toxicity 95%
- Amyloid plaque deposition accelerates tau propagation via activation of microglia in a humanized APP mouse model 95%
- APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology 94%
Similar papers in this journal
- Rare genetic variation in Fibronectin 1 (FN1) protects against APOEe4 in Alzheimer's disease 96%
- Tau phosphorylated at serine 356 is associated with Alzheimer's disease pathology and can be lowered in mouse and human brain tissue using the NUAK inhibitor WZ4003 95%
- Genome-wide association study and functional validation implicates JADE1 in tauopathy 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.